COVACERT, created in 2007 (United States), from 142 sister brands and 17477 competing brands. COVACERT is a brand of Amgen, listed on the stock exchange of New York. COVACERT belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
Amgen
(COVACERT)
over 5 years*
USD 392.06